Database Query Results : Resveratrol, ,

RES, Resveratrol: Click to Expand ⟱
Features: polyphenol
Found in red grapes and products made with grapes.
Resveratrol is a polyphenol compound found in various plant species, including grapes, berries, and peanuts.
• Anti-inflammatory effects, Antioxidant effects:
- Antiplatelet aggregation for stroke prevention
- BioAvialability use piperine
- some sources may use Japanese knotweed roots (Reynoutria Japonica - root) as source which might contain Emodin (laxative)
-known as Nrf2 activator, both in cancer and normal cells. Which raises controversity of use in ROS↑ therapies. Interestingly there are reports of NRF2↑ and ROS↑ in cancer cells. This raises the question of if it is a chemosensitizer. However other reports indicate NRF2 droping with Res, indicating it maybe a chemosenstizer.
- RES is also considered to be them most effective natural SIRT1↑ -activating compound (STACs).

However, in the presence of certain metals, such as copper or iron, resveratrol can undergo a process called Fenton reaction, which can lead to the generation of reactive oxygen species (ROS). The pro-oxidant effects of resveratrol are often observed at high concentrations, typically above 50-100 μM, and in the presence of certain metals or other pro-oxidant agents. In contrast, the antioxidant effects of resveratrol are typically observed at lower concentrations, typically below 10-20 μM.

Clinical trials have used doses ranging from 150 mg to 5 grams per day. Lower doses (< 1 g/day) are often well-tolerated, but higher doses might be necessary for therapeutic effects and can be associated with side effects.

-Note half-life 1-3 hrs?.
BioAv poor: min 5uM/L required for chemopreventive effects, but 25mg Oral only yeilds 20nM. co-administration of piperine
Pathways:
- usually induce ROS production in cancer cells, while reducing ROS in normal cells.
- ROS↑ related: MMP↓(ΔΨm), ER Stress↑, UPR↑, GRP78↑, Ca+2↑, Cyt‑c↑, Caspases↑, DNA damage↑, cl-PARP↑, HSP↓,
- Lowers AntiOxidant defense in Cancer Cells: NRF2(typically increased), TrxR↓**, SOD↓, GSH↓ Catalase↓ HO1↓(wrong direction), GPx↓
- Raises AntiOxidant defense in Normal Cells: ROS↓, NRF2↑, SOD↑, GSH↑, Catalase↑,
- lowers Inflammation : NF-kB↓, COX2↓, p38↓, Pro-Inflammatory Cytokines : NLRP3↓, IL-1β↓, TNF-α↓, IL-6↓, IL-8↓
- inhibit Growth/Metastases : TumMeta↓, TumCG↓, EMT↓, MMPs↓, MMP2↓, MMP9↓, TIMP2, IGF-1↓, uPA↓, VEGF↓, ROCK1↓, FAK↓, RhoA↓, NF-κB↓, CXCR4↓, SDF1↓, TGF-β↓, α-SMA↓, ERK↓
- reactivate genes thereby inhibiting cancer cell growth : HDAC↓, EZH2↓, P53↑, HSP↓, Sp proteins↓,
- cause Cell cycle arrest : TumCCA↑, cyclin D1↓, cyclin E↓, CDK2↓, CDK4↓, CDK6↓,
- inhibits Migration/Invasion : TumCMig↓, TumCI↓, TNF-α↓, FAK↓, ERK↓, EMT↓, TOP1↓, TET1↓,
- inhibits glycolysis /Warburg Effect and ATP depletion : HIF-1α↓, PKM2↓, cMyc↓, GLUT1↓, LDH↓, LDHA↓, HK2↓, PFKs↓, PDKs↓, ECAR↓, OXPHOS↓, GRP78↑, Glucose↓, GlucoseCon↓
- inhibits angiogenesis↓ : VEGF↓, HIF-1α↓, Notch↓, FGF↓, PDGF↓, EGFR↓, Integrins↓,
- inhibits Cancer Stem Cells : CSC↓, CK2↓, Hh↓, CD133↓, CD24↓, β-catenin↓, sox2↓, notch2↓, nestin↓, OCT4↓,
- Others: PI3K↓, AKT↓, JAK↓, STAT↓, Wnt↓, β-catenin↓, AMPK, ERK↓, JNK,
- Synergies: chemo-sensitization, chemoProtective, RadioSensitizer, RadioProtective, Others(review target notes), Neuroprotective, Cognitive, Renoprotection, Hepatoprotective, CardioProtective,

- Selectivity: Cancer Cells vs Normal Cells

Rank Pathway / Axis Cancer Cells Normal Cells Label Primary Interpretation Notes
1 Reactive oxygen species (ROS) ↑ ROS (dose- & context-dependent) ↓ ROS / buffered Conditional Driver Biphasic redox modulation Resveratrol can act as a pro-oxidant in cancer cells while functioning as an antioxidant in normal cells
2 Mitochondrial integrity / intrinsic apoptosis ↓ ΔΨm; ↑ caspase activation ↔ preserved Driver Execution of intrinsic apoptosis Mitochondrial dysfunction and apoptosis follow ROS elevation in cancer cells
3 SIRT1 / AMPK axis ↑ AMPK; context-dependent SIRT1 modulation ↑ SIRT1 / ↑ AMPK Driver Metabolic stress signaling Resveratrol modulates energy-sensing pathways affecting survival and metabolism
4 PI3K → AKT → mTOR axis ↓ AKT / ↓ mTOR ↔ adaptive suppression Secondary Growth and anabolic inhibition Downregulation of growth signaling contributes to cytostasis and apoptosis sensitization
5 NF-κB signaling ↓ NF-κB activation ↓ inflammatory NF-κB tone Secondary Suppression of survival and inflammatory transcription NF-κB inhibition contributes to reduced proliferation and invasion
6 Cell cycle regulation ↑ G1/S or G2/M arrest ↔ largely spared Phenotypic Cytostatic growth control Cell-cycle arrest reflects upstream signaling disruption
7 HIF-1α / VEGF axis ↓ HIF-1α; ↓ VEGF ↔ minimal Secondary Anti-angiogenic pressure Interference with hypoxia-driven adaptation and angiogenesis


Scientific Papers found: Click to Expand⟱
2206- AgNPs,  RES,    ENHANCED EFFICACY OF RESVERATROL-LOADED SILVER NANOPARTICLE IN ATTENUATING SEPSIS-INDUCED ACUTE LIVER INJURY: MODULATION OF INFLAMMATION, OXIDATIVE STRESS, AND SIRT1 ACTIVATION
- in-vivo, Nor, NA
"highlight2" >*hepatoP↑, "highlight2" >*Inflam↓, "highlight2" >*NF-kB↓, "highlight2" >*VEGF↓, "highlight2" >*SIRT1↑, "highlight2" >*ROS↓, "highlight2" >*Dose↝, "highlight2" >*Catalase↑, "highlight2" >*MDA↓, "highlight2" >*MPO↓, "highlight2" >*NO↓, "highlight2" >*ALAT↓, "highlight2" >*AST↓, "highlight2" >*antiOx↑,
2578- ART/DHA,  RES,    Synergic effects of artemisinin and resveratrol in cancer cells
- in-vitro, Liver, HepG2 - in-vitro, Cerv, HeLa
"highlight2" >Dose↝, "highlight2" >TumCMig↓, "highlight2" >Apoptosis↑, "highlight2" >necrosis↑, "highlight2" >ROS↑, "highlight2" >eff↑,
16- CP,  RES,    Resveratrol inhibits the hedgehog signaling pathway and epithelial-mesenchymal transition and suppresses gastric cancer invasion and metastasis
- in-vitro, GC, SGC-7901
"highlight2" >HH↓, "highlight2" >Gli1↓, "highlight2" >EMT↓, "highlight2" >N-cadherin↓, "highlight2" >E-cadherin↑, "highlight2" >Snail↓, "highlight2" >TumCI↓, "highlight2" >TumMeta↓,
3862- CUR,  RES,    The metalloproteinase ADAM10: A useful therapeutic target?
- Review, AD, NA
"highlight2" >*SIRT1↑, "highlight2" >*ADAM10↑,
3748- CUR,  RES,  Hup,  Riv,  Gala  Natural acetylcholinesterase inhibitors: A multi-targeted therapeutic potential in Alzheimer's disease
- Review, AD, NA
"highlight2" >*AChE↓, "highlight2" >*Inflam↓, "highlight2" >*Aβ↓, "highlight2" >*cognitive↑, "highlight2" >*ROS↓,
128- CUR,  RES,    Evaluation of biophysical as well as biochemical potential of curcumin and resveratrol during prostate cancer
- in-vivo, Pca, NA
"highlight2" >lipid-P↓, "highlight2" >chemoPv↑, "highlight2" >GSH↑, "highlight2" >SOD↑, "highlight2" >GSTs↑, "highlight2" >glucose↓,
134- CUR,  RES,  MEL,  SIL,    Thioredoxin 1 modulates apoptosis induced by bioactive compounds in prostate cancer cells
- in-vitro, Pca, LNCaP - in-vitro, Pca, PC3
"highlight2" >Apoptosis↑, "highlight2" >ROS↑, "highlight2" >Trx1↓, "highlight2" >TumCG↓, "highlight2" >eff↓, "highlight2" >TXNIP↑,
182- CUR,  RES,  GI,    Chemopreventive anti-inflammatory activities of curcumin and other phytochemicals mediated by MAP kinase phosphatase-5 in prostate cells
- in-vitro, Pca, DU145 - in-vitro, Pca, PC3 - in-vitro, Pca, LNCaP - in-vitro, Pca, LAPC-4
"highlight2" >p38↓, "highlight2" >MKP5↑, "highlight2" >TNF-α↓, "highlight2" >COX2↓, "highlight2" >NF-kB↓,
872- CUR,  RES,    New Insights into Curcumin- and Resveratrol-Mediated Anti-Cancer Effects
- in-vitro, BC, TUBO - in-vitro, BC, SALTO
"highlight2" >TumCP↓, "highlight2" >tumCV↓, "highlight2" >p62↓, "highlight2" >p62↑, "highlight2" >TumAuto↑, "highlight2" >TumAuto↓, "highlight2" >ROS↑, "highlight2" >ROS↓, "highlight2" >CHOP↑,
1383- CUR,  BBR,  RES,    Regulation of GSK-3 activity by curcumin, berberine and resveratrol: Potential effects on multiple diseases
- Review, NA, NA
"highlight2" >GSK‐3β↝, "highlight2" >ROS↑,
4881- CUR,  SFN,  RES,  EGCG,  Lyco  An update of Nrf2 activators and inhibitors in cancer prevention/promotion
- Review, Var, NA
"highlight2" >*NRF2↑, "highlight2" >*antiOx↑,
5397- CUR,  SFN,  RES,  EGCG,  Ash  Targeting Cancer Stem Cells with Phytochemicals: Molecular Mechanisms and Therapeutic Potential
- Review, Var, NA
"highlight2" >CSCs↓,
685- EGCG,  CUR,  SFN,  RES,  GEN  The “Big Five” Phytochemicals Targeting Cancer Stem Cells: Curcumin, EGCG, Sulforaphane, Resveratrol and Genistein
- Analysis, NA, NA
"highlight2" >Bcl-2↓, "highlight2" >survivin↓, "highlight2" >XIAP↓, "highlight2" >EMT↓, "highlight2" >Apoptosis↑, "highlight2" >Nanog↓, "highlight2" >cMyc↓, "highlight2" >OCT4↓, "highlight2" >Snail↓, "highlight2" >Slug↓, "highlight2" >Zeb1↓, "highlight2" >TCF↓,
4664- GEN,  CUR,  RES,  EGCG,  SFN  Targeting cancer stem cells by nutraceuticals for cancer therapy
- Review, Var, NA
"highlight2" >CSCs↓, "highlight2" >other↝, "highlight2" >eff↑, "highlight2" >CD44↓, "highlight2" >p‑STAT3↓,
166- GEN,  EGCG,  RES,  CUR,    Common botanical compounds inhibit the hedgehog signaling pathway in prostate cancer
- in-vivo, Pca, NA
"highlight2" >HH↓, "highlight2" >Gli1↓,
1534- LT,  Api,  EGCG,  RES,    Plant polyphenol induced cell death in human cancer cells involves mobilization of intracellular copper ions and reactive oxygen species generation: a mechanism for cancer chemopreventive action
- in-vitro, Nor, MCF10 - in-vitro, BC, MDA-MB-231 - in-vitro, BC, MDA-MB-468 - in-vitro, PC, Bxpc-3
"highlight2" >TumCP↓, "highlight2" >Apoptosis↑, "highlight2" >eff↓, "highlight2" >*toxicity↑, "highlight2" >Dose?, "highlight2" >eff↓, "highlight2" >eff↓,
1721- Lyco,  RES,  VitC,    Lycopene, resveratrol, vitamin C and FeSO4 increase damage produced by pro-oxidant carcinogen 4-nitroquinoline-1-oxide in Drosophila melanogaster: Xenobiotic metabolism implications.
- in-vitro, Pca, PC3 - in-vitro, Lung, A549 - in-vitro, Cerv, HeLa - in-vitro, BC, MCF-7 - in-vitro, Liver, HepG2
"highlight2" >ROS↑,
4701- PTS,  RES,    Targeting cancer stem cells and signaling pathways by resveratrol and pterostilbene
- Review, Var, NA
"highlight2" >CSCs↓, "highlight2" >E-cadherin↑, "highlight2" >NF-kB↓, "highlight2" >EMT↓, "highlight2" >GRP78/BiP↓, "highlight2" >CD133↓, "highlight2" >COX2↓, "highlight2" >β-catenin/ZEB1↓, "highlight2" >NOTCH↓,
4703- PTS,  RES,    Pterostilbene and resveratrol: Exploring their protective mechanisms against skin photoaging - A scoping review
- NA, Nor, NA
"highlight2" >*AntiAge↑, "highlight2" >*eff↑, "highlight2" >*Inflam↓, "highlight2" >*AntiCan↑, "highlight2" >*ROS↓, "highlight2" >*Catalase↑, "highlight2" >*GSR↑, "highlight2" >*HO-1↑, "highlight2" >*NAD↑, "highlight2" >*NQO1↑, "highlight2" >*SOD↑, "highlight2" >*NRF2↑,
67- QC,  RES,    Overexpression of c-Jun induced by quercetin and resverol inhibits the expression and function of the androgen receptor in human prostate cancer cells
- in-vitro, Pca, LNCaP - in-vitro, Pca, LAPC-4
"highlight2" >cJun↑, "highlight2" >AR↓,
873- QC,  RES,  CUR,  PI,    Combination Effects of Quercetin, Resveratrol and Curcumin on In Vitro Intestinal Absorption
- in-vitro, Nor, NA
"highlight2" >*BioEnh↑,
3080- RES,    Resveratrol: A miraculous natural compound for diseases treatment
- Review, Var, NA
"highlight2" >SIRT1↑, "highlight2" >ROCK1↓, "highlight2" >AMPK↑, "highlight2" >*lipid-P↓, "highlight2" >Aβ↓, "highlight2" >COX2↓, "highlight2" >angioG↓, "highlight2" >Hif1a↓, "highlight2" >VEGF↓,
3073- RES,    Resveratrol inhibits NLRP3 inflammasome activation by preserving mitochondrial integrity and augmenting autophagy
- in-vitro, Nor, NA
"highlight2" >*NLRP3↓, "highlight2" >*mtDam↓, "highlight2" >*p38↑,
3074- RES,    Possible therapeutic targets for NLRP3 inflammasome-induced breast cancer
- Review, BC, NA
"highlight2" >NLRP3↓, "highlight2" >SIRT1↑,
3075- RES,  Rad,    The Protection Effect of Resveratrol Against Radiation-Induced Inflammatory Bowel Disease via NLRP-3 Inflammasome Repression in Mice
- in-vivo, Nor, NA
"highlight2" >*SIRT1↑, "highlight2" >*radioP↑, "highlight2" >*NLRP3↓, "highlight2" >*Weight↑, "highlight2" >*IL1β↓,
3076- RES,    Resveratrol for targeting the tumor microenvironment and its interactions with cancer cells
- Review, Var, NA
"highlight2" >IL6↓, "highlight2" >MMPs↓, "highlight2" >MMP2↓, "highlight2" >MMP9↓, "highlight2" >BioAv↓, "highlight2" >Half-Life↑, "highlight2" >BioAv↑, "highlight2" >Dose↝, "highlight2" >angioG↓, "highlight2" >IL10↓, "highlight2" >VEGF↓, "highlight2" >NF-kB↓, "highlight2" >COX2↓, "highlight2" >SIRT1↑, "highlight2" >Wnt↓, "highlight2" >cMyc↓, "highlight2" >STAT3↓, "highlight2" >PTEN↑, "highlight2" >ROS↑, "highlight2" >RadioS↑, "highlight2" >Hif1a↓, "highlight2" >E-cadherin↓, "highlight2" >Vim↓, "highlight2" >angioG↓,
3077- RES,    Resveratrol attenuates matrix metalloproteinase-9 and -2-regulated differentiation of HTB94 chondrosarcoma cells through the p38 kinase and JNK pathways
- in-vitro, Chon, HTB94
"highlight2" >MMP2↓, "highlight2" >MMP9↓, "highlight2" >SOX9↑, "highlight2" >MMPs↓, "highlight2" >p‑p38↑, "highlight2" >p‑JNK↓, "highlight2" >NF-kB↓, "highlight2" >HO-1↓,
3078- RES,    The Effects of Resveratrol on Prostate Cancer through Targeting the Tumor Microenvironment
- Review, Pca, NA
"highlight2" >*ROS↓, "highlight2" >ROS↑, "highlight2" >DNAdam↑, "highlight2" >Apoptosis↑, "highlight2" >Hif1a↑, "highlight2" >Casp3↑, "highlight2" >Casp9↑, "highlight2" >Cyt‑c↑, "highlight2" >Dose↝, "highlight2" >MMPs↓, "highlight2" >MMP2↓, "highlight2" >MMP9↓, "highlight2" >EMT↓, "highlight2" >E-cadherin↑, "highlight2" >N-cadherin↓, "highlight2" >AR↓,
3079- RES,    Therapeutic role of resveratrol against hepatocellular carcinoma: A review on its molecular mechanisms of action
- Review, Var, NA
"highlight2" >angioG↓, "highlight2" >TumMeta↓, "highlight2" >ChemoSen↑, "highlight2" >NADPH↑, "highlight2" >SIRT1↑, "highlight2" >NF-kB↓, "highlight2" >NLRP3↓, "highlight2" >Dose↝, "highlight2" >COX2↓, "highlight2" >MMP9↓, "highlight2" >PGE2↓, "highlight2" >TIMP1↑, "highlight2" >TIMP2↑, "highlight2" >Sp1/3/4↓, "highlight2" >p‑JNK↓, "highlight2" >uPAR↓, "highlight2" >ROS↓, "highlight2" >CXCR4↓, "highlight2" >IL6↓, "highlight2" >Gli1↓, "highlight2" >*ROS↓, "highlight2" >*GSTs↑, "highlight2" >*SOD↑, "highlight2" >*Catalase↑, "highlight2" >*GPx↑, "highlight2" >*lipid-P↓, "highlight2" >*GSH↑, "highlight2" >eff↑, "highlight2" >eff↑, "highlight2" >eff↑,
3072- RES,    Resveratrol ameliorates glioblastoma inflammatory response by reducing NLRP3 inflammasome activation through inhibition of the JAK2/STAT3 pathway
- in-vitro, GBM, LN229 - in-vitro, GBM, U87MG
"highlight2" >tumCV↓, "highlight2" >TumCP↓, "highlight2" >TumCMig↓, "highlight2" >Apoptosis↑, "highlight2" >NLRP3↓, "highlight2" >JAK2↓, "highlight2" >STAT3↓, "highlight2" >IL1β↓, "highlight2" >IL18↓, "highlight2" >IL6↓, "highlight2" >TNF-α↓, "highlight2" >Inflam↓,
3081- RES,    Resveratrol and p53: How are they involved in CRC plasticity and apoptosis?
- Review, CRC, NA
"highlight2" >NF-kB↓, "highlight2" >FAK↓, "highlight2" >Ki-67↓, "highlight2" >MMP9↓, "highlight2" >CSCs↓, "highlight2" >CD44↓, "highlight2" >CD133↓, "highlight2" >ALDH1A1↓, "highlight2" >EMT↓, "highlight2" >ChemoSen↑, "highlight2" >Hif1a↓, "highlight2" >ITGB1↓, "highlight2" >Inflam↓,
3082- RES,    Resveratrol Ameliorates the Malignant Progression of Pancreatic Cancer by Inhibiting Hypoxia-induced Pancreatic Stellate Cell Activation
- in-vitro, PC, PANC1 - in-vitro, PC, MIA PaCa-2 - in-vivo, NA, NA
"highlight2" >VEGF↓, "highlight2" >CXCL12↓, "highlight2" >IL6↓, "highlight2" >α-SMA↓, "highlight2" >Hif1a↓, "highlight2" >TumCI↓, "highlight2" >EMT↓,
3083- RES,    Resveratrol suppresses breast cancer cell invasion by inactivating a RhoA/YAP signaling axis
- in-vitro, BC, MDA-MB-231 - in-vitro, BC, MDA-MB-468
"highlight2" >YAP/TEAD↓, "highlight2" >Rho↓, "highlight2" >FAK↓, "highlight2" >MMP9↓, "highlight2" >ChemoSen↑, "highlight2" >RAS↓, "highlight2" >ROCK1↓, "highlight2" >TumCI↓, "highlight2" >TumMeta↓,
3084- RES,    Resveratrol inhibits the proliferation of estrogen receptor-positive breast cancer cells by suppressing EZH2 through the modulation of ERK1/2 signaling
- in-vitro, BC, MCF-7 - in-vitro, BC, T47D
"highlight2" >TumCP↓, "highlight2" >EZH2↓, "highlight2" >p‑ERK↓,
3085- RES,    Resveratrol interrupts Wnt/β-catenin signalling in cervical cancer by activating ten-eleven translocation 5-methylcytosine dioxygenase 1
- in-vitro, Cerv, NA
"highlight2" >TET1↑, "highlight2" >Wnt↓, "highlight2" >β-catenin/ZEB1↓,
3086- RES,    Resveratrol inhibits the tumor migration and invasion by upregulating TET1 and reducing TIMP2/3 methylation in prostate carcinoma cells
- in-vitro, Pca, LNCaP - in-vitro, Pca, PC3 - in-vitro, Pca, DU145
"highlight2" >TET1↑, "highlight2" >TumCMig↓, "highlight2" >TumCI↓, "highlight2" >TIMP2↑, "highlight2" >TIMP3↑, "highlight2" >MMP2↓, "highlight2" >MMP9↓,
3087- RES,    Resveratrol cytotoxicity is energy-dependent
- Review, Var, NA
"highlight2" >OXPHOS↓, "highlight2" >eff↝, "highlight2" >eff↑,
3088- RES,    Notch signaling mediated repressive effects of resveratrol in inducing caspasedependent apoptosis in MCF-7 breast cancer cells
- in-vitro, BC, MCF-7
"highlight2" >NOTCH1↓, "highlight2" >BAX↑, "highlight2" >CDK4↝, "highlight2" >Casp3↑, "highlight2" >P21↑,
3089- RES,    The Role of Resveratrol in Cancer Therapy
- Review, Var, NA
"highlight2" >angioG↓, "highlight2" >VEGF↓, "highlight2" >EGFR↓, "highlight2" >FGF↑, "highlight2" >TumCMig↓, "highlight2" >TumCI↓, "highlight2" >TIMP1↑, "highlight2" >MMP2↓, "highlight2" >MMP9↓, "highlight2" >NF-kB↓, "highlight2" >Hif1a↓, "highlight2" >PI3K↓, "highlight2" >Akt↓, "highlight2" >MAPK↓, "highlight2" >EMT↓, "highlight2" >AR↓,
3071- RES,    Resveratrol and Its Anticancer Effects
- Review, Var, NA
"highlight2" >chemoPv↑, "highlight2" >SIRT1↑, "highlight2" >Hif1a↓, "highlight2" >VEGF↓, "highlight2" >STAT3↓, "highlight2" >NF-kB↓, "highlight2" >COX2↓, "highlight2" >PI3K↓, "highlight2" >mTOR↓, "highlight2" >NRF2↑, "highlight2" >NLRP3↓, "highlight2" >H2O2↑, "highlight2" >ROS↑, "highlight2" >P53↑, "highlight2" >PUMA↑, "highlight2" >BAX↑,
3070- RES,    Resveratrol inhibits tumor progression by down-regulation of NLRP3 in renal cell carcinoma
- in-vitro, RCC, ACHN - in-vitro, RCC, 786-O - in-vivo, NA, NA
"highlight2" >TumCP↓, "highlight2" >TumCMig↓, "highlight2" >TumCI↓, "highlight2" >Apoptosis↑, "highlight2" >NLRP3↓,
3069- RES,    Resveratrol Inhibits NLRP3 Inflammasome-Induced Pyroptosis and miR-155 Expression in Microglia Through Sirt1/AMPK Pathway
- in-vitro, Nor, N9
"highlight2" >*antiOx↑, "highlight2" >*Inflam↓, "highlight2" >*ROS↓, "highlight2" >*NF-kB↓, "highlight2" >*AMPK↑, "highlight2" >*SIRT1↑, "highlight2" >*miR-155↓, "highlight2" >*NLRP3↓,
3068- RES,    Resveratrol decreases the expression of genes involved in inflammation through transcriptional regulation
- in-vitro, lymphoma, U937
"highlight2" >p65↓, "highlight2" >SOD2↓, "highlight2" >Prx↓, "highlight2" >Catalase↓, "highlight2" >Trx↓, "highlight2" >TNF-α↓, "highlight2" >IL8↓, "highlight2" >MCP1↓, "highlight2" >SIRT1↑,
3067- RES,    Proteomic Profiling Reveals That Resveratrol Inhibits HSP27 Expression and Sensitizes Breast Cancer Cells to Doxorubicin Therapy
- in-vitro, BC, MCF-7
"highlight2" >Apoptosis↑, "highlight2" >MMP↓, "highlight2" >Cyt‑c↑, "highlight2" >Casp3↑, "highlight2" >Casp9↑, "highlight2" >HSP27↓,
3066- RES,    Resveratrol triggers ER stress-mediated apoptosis by disrupting N-linked glycosylation of proteins in ovarian cancer cells
"highlight2" >GSK‐3β↑, "highlight2" >Akt↓, "highlight2" >CHOP↑, "highlight2" >ER Stress↑, "highlight2" >PERK↑, "highlight2" >ATF6↑, "highlight2" >UPR↑, "highlight2" >GlucoseCon↓,
3065- RES,    Resveratrol-induced cytotoxicity in human Burkitt's lymphoma cells is coupled to the unfolded protein response
- in-vitro, lymphoma, NA
"highlight2" >UPR↑, "highlight2" >IRE1↑, "highlight2" >p‑eIF2α↑, "highlight2" >PERK↑, "highlight2" >ATF6↑, "highlight2" >GRP78/BiP↑, "highlight2" >GRP94↑, "highlight2" >CHOP↑, "highlight2" >GADD34↑, "highlight2" >ATF4↑, "highlight2" >XBP-1↑, "highlight2" >Ca+2↑, "highlight2" >ER Stress↑,
3064- RES,    Resveratrol Suppresses Cancer Cell Glucose Uptake by Targeting Reactive Oxygen Species–Mediated Hypoxia-Inducible Factor-1α Activation
- in-vitro, CRC, HT-29 - in-vitro, BC, T47D - in-vitro, Lung, LLC1
"highlight2" >FDG↓, "highlight2" >ROS↓, "highlight2" >Hif1a↓, "highlight2" >GLUT1↓, "highlight2" >lactateProd↓,
3063- RES,    Resveratrol: A Review of Pre-clinical Studies for Human Cancer Prevention
- Review, Var, NA
"highlight2" >*Inflam↓, "highlight2" >*antiOx↑, "highlight2" >*AntiAg↑, "highlight2" >*chemoPv↑, "highlight2" >ChemoSen↑, "highlight2" >BioAv↑, "highlight2" >Half-Life↝, "highlight2" >COX2↓, "highlight2" >cycD1/CCND1↓, "highlight2" >CDK2↓, "highlight2" >CDK4↓, "highlight2" >CDK6↓, "highlight2" >P21↑, "highlight2" >MMP9↓, "highlight2" >NF-kB↓, "highlight2" >Telomerase↓, "highlight2" >PSA↓, "highlight2" >MAPK↑, "highlight2" >P53↑,
3062- RES,    Resveratrol enhances post-injury muscle regeneration by regulating antioxidant and mitochondrial biogenesis
- in-vivo, Nor, NA
"highlight2" >*antiOx↑, "highlight2" >*Keap1↓, "highlight2" >*NRF2↑, "highlight2" >*HO-1↑, "highlight2" >*GPx↑, "highlight2" >*SOD↑,
3061- RES,    The Anticancer Effects of Resveratrol: Modulation of Transcription Factors
- Review, Var, NA
"highlight2" >AhR↓, "highlight2" >NRF2↑, "highlight2" >*NQO1↑, "highlight2" >*HO-1↑, "highlight2" >*GSH↑, "highlight2" >P53↑, "highlight2" >Cyt‑c↑, "highlight2" >Diablo↑, "highlight2" >Bcl-2↓, "highlight2" >Bcl-xL↓, "highlight2" >survivin↓, "highlight2" >XIAP↓, "highlight2" >FOXO↑, "highlight2" >p‑PI3K↓, "highlight2" >p‑Akt↓, "highlight2" >BIM↑, "highlight2" >DR4↑, "highlight2" >DR5↑, "highlight2" >p27↑, "highlight2" >cycD1/CCND1↓, "highlight2" >SIRT1↑, "highlight2" >NF-kB↓, "highlight2" >ATF3↑,
3060- RES,    Resveratrol targeting NRF2 disrupts the binding between KEAP1 and NRF2-DLG motif to ameliorate oxidative stress damage in mice pulmonary infection
- in-vitro, Nor, RAW264.7 - in-vivo, NA, NA
"highlight2" >*NRF2↑, "highlight2" >*antiOx↑, "highlight2" >*ROS↓,
3059- RES,    Resveratrol, an Nrf2 activator, ameliorates aging-related progressive renal injury
- in-vivo, Nor, HK-2
"highlight2" >*RenoP↑, "highlight2" >*Inflam↓, "highlight2" >*NRF2↑, "highlight2" >*HO-1↑, "highlight2" >*SIRT1↑, "highlight2" >*ROS↓, "highlight2" >AntiAge↑,
3058- RES,    Resveratrol inhibits estrogen-induced breast carcinogenesis through induction of NRF2-mediated protective pathways
- in-vivo, NA, NA
"highlight2" >*Nrf1?,
3057- RES,    The therapeutic effect of resveratrol: Focusing on the Nrf2 signaling pathway
- Review, Var, NA - Review, AD, NA - Review, Stroke, NA
"highlight2" >*NRF2↑, "highlight2" >*Keap1↓, "highlight2" >*ROS↓, "highlight2" >*Apoptosis↓, "highlight2" >*Inflam↓, "highlight2" >*antiOx↑, "highlight2" >*hepatoP↑, "highlight2" >*neuroP↑, "highlight2" >*cardioP↑, "highlight2" >*RenoP↑, "highlight2" >*AntiCan↑, "highlight2" >*memory↑, "highlight2" >*SOD↑, "highlight2" >*GPx↑, "highlight2" >*Catalase↑, "highlight2" >*MDA↓, "highlight2" >*NRF2↑, "highlight2" >*HO-1↑, "highlight2" >*ROS↓, "highlight2" >*Aβ↓, "highlight2" >*iNOS↓, "highlight2" >*COX2↓, "highlight2" >*GSH↑, "highlight2" >*HO-1⇅, "highlight2" >*SIRT1↑,
3798- RES,    Resveratrol reverses hippocampal synaptic markers injury and SIRT1 inhibition against developmental Pb exposure
- in-vivo, NA, NA
"highlight2" >*SIRT1↑, "highlight2" >*BDNF↑, "highlight2" >*PSD95↑, "highlight2" >*memory↑,
101- RES,    Resveratrol inhibits the hedgehog signaling pathway and epithelial-mesenchymal transition and suppresses gastric cancer invasion and metastasis
- in-vitro, GC, SGC-7901
"highlight2" >HH↓, "highlight2" >Gli1↓, "highlight2" >EMT↓, "highlight2" >Snail↓, "highlight2" >N-cadherin↓, "highlight2" >E-cadherin↑, "highlight2" >TumCI↓, "highlight2" >TumMeta↓,
4663- RES,    Exploring resveratrol’s inhibitory potential on lung cancer stem cells: a scoping review of mechanistic pathways across cancer models
- Review, Var, NA
"highlight2" >*antiOx↑, "highlight2" >*Inflam↓, "highlight2" >*chemoPv↑, "highlight2" >CSCs↓, "highlight2" >Wnt↓, "highlight2" >β-catenin/ZEB1↓, "highlight2" >NOTCH↓, "highlight2" >PI3K↓, "highlight2" >Akt↓, "highlight2" >mTOR↓, "highlight2" >GSK‐3β↝, "highlight2" >Snail↓, "highlight2" >HH↓, "highlight2" >p‑GSK‐3β↓, "highlight2" >N-cadherin↓, "highlight2" >EMT↓, "highlight2" >CD133↓, "highlight2" >CD44↓, "highlight2" >ALDH1A1↓, "highlight2" >OCT4↓, "highlight2" >SOX4↓, "highlight2" >Shh↓, "highlight2" >Smo↓, "highlight2" >Gli1↓, "highlight2" >GLI2↓,
4662- RES,    A Promising Resveratrol Analogue Suppresses CSCs in Non-Small-Cell Lung Cancer via Inhibition of the ErbB2 Signaling Pathway
- in-vitro, NSCLC, A549 - in-vitro, NSCLC, H460
"highlight2" >CSCs↓, "highlight2" >CD133↓, "highlight2" >OCT4↓, "highlight2" >β-catenin/ZEB1↓, "highlight2" >HER2/EBBR2↓, "highlight2" >TumCP↓, "highlight2" >PI3K↓, "highlight2" >Akt↓, "highlight2" >ALDH1A1↓, "highlight2" >eff↑,
4657- RES,    Resveratrol, cancer and cancer stem cells: A review on past to future
- Review, Var, NA
"highlight2" >CSCs↓, "highlight2" >CD133↓, "highlight2" >Shh↓, "highlight2" >Twist↓, "highlight2" >Snail↓, "highlight2" >MMP2↓, "highlight2" >MMP9↓, "highlight2" >Smad1↓, "highlight2" >CD44↓, "highlight2" >ALDH1A1↓, "highlight2" >OCT4↓, "highlight2" >Nanog↓, "highlight2" >STAT3↓, "highlight2" >survivin↓, "highlight2" >cycD1/CCND1↓, "highlight2" >COX2↓, "highlight2" >cMyc↓,
4289- RES,    Resveratrol Attenuates Formaldehyde Induced Hyperphosphorylation of Tau Protein and Cytotoxicity in N2a Cells
- in-vitro, AD, NA
"highlight2" >*antiOx↑, "highlight2" >*p‑tau↓, "highlight2" >*GSK‐3β↓, "highlight2" >*CaMKII ↓, "highlight2" >*PP2A↑, "highlight2" >*neuroP↑,
4288- RES,    Trans-resveratrol Inhibits Tau Phosphorylation in the Brains of Control and Cadmium Chloride-Treated Rats by Activating PP2A and PI3K/Akt Induced-Inhibition of GSK3β
- in-vivo, AD, NA
"highlight2" >*memory↑, "highlight2" >*GSH↑, "highlight2" >*ROS↓, "highlight2" >*MDA↓, "highlight2" >*p‑tau↓, "highlight2" >*PI3K↑, "highlight2" >*Akt↑, "highlight2" >*AMPK↑, "highlight2" >*PP2A↑, "highlight2" >*GSK‐3β↓,
4287- RES,    Resveratrol targeting tau proteins, amyloid-beta aggregations, and their adverse effects: An updated review
- Review, AD, NA
"highlight2" >*p‑tau↓,
4286- RES,    Neuroprotective Properties of Resveratrol and Its Derivatives—Influence on Potential Mechanisms Leading to the Development of Alzheimer’s Disease
- Review, AD, NA
"highlight2" >*neuroP↑, "highlight2" >*Inflam↓, "highlight2" >*antiOx↑, "highlight2" >*GSH↑, "highlight2" >*HO-1↑, "highlight2" >*iNOS↓, "highlight2" >*BDNF↑, "highlight2" >*p‑CREB↑, "highlight2" >*PKA↑, "highlight2" >*Bcl-2↑, "highlight2" >*BAX↓, "highlight2" >*IL1β↓, "highlight2" >*IL6↓, "highlight2" >*MMP9↓, "highlight2" >*memory↑, "highlight2" >*AMPK↑, "highlight2" >*PGC-1α↓, "highlight2" >*NF-kB↓, "highlight2" >*Aβ↓, "highlight2" >*SIRT1↑, "highlight2" >*p‑tau↓, "highlight2" >*PP2A↑, "highlight2" >*lipid-P↓, "highlight2" >*NLRP3↓, "highlight2" >*BACE↓,
4285- RES,    Resveratrol Rescues Tau-Induced Cognitive Deficits and Neuropathology in a Mouse Model of Tauopathy
- in-vivo, AD, NA
"highlight2" >*tau↓, "highlight2" >*cognitive↑, "highlight2" >*Inflam↓,
4284- RES,    Resveratrol induces dephosphorylation of Tau by interfering with the MID1-PP2A complex
- in-vitro, AD, HEK293 - NA, Stroke, NA - in-vivo, AD, NA
"highlight2" >*p‑tau↓, "highlight2" >*PP2A↑, "highlight2" >*neuroP↑, "highlight2" >*antiOx↑, "highlight2" >COX2↓, "highlight2" >*AntiAg↑, "highlight2" >*SIRT1↑, "highlight2" >*AMPK↑, "highlight2" >*Acetyl-CoA↓, "highlight2" >*FAO↑, "highlight2" >*ADAM10↑, "highlight2" >*BACE↓, "highlight2" >*Aβ↓, "highlight2" >*memory↑, "highlight2" >*Inflam↓, "highlight2" >*ROS↓,
4154- RES,    Resveratrol improves postnatal hippocampal neurogenesis and brain derived neurotrophic factor in prenatally stressed rats
- in-vivo, AD, NA
"highlight2" >*neuroP↑, "highlight2" >*BDNF↑,
4153- RES,    Effect of oral resveratrol on the BDNF gene expression in the hippocampus of the rat brain
- in-vivo, AD, NA
"highlight2" >*neuroP↑, "highlight2" >*BDNF↑,
3863- RES,  MEL,  VitA,RetA,    Target Enzymes Considered for the Treatment of Alzheimer's Disease and Parkinson's Disease
- Review, AD, NA - Review, Park, NA
"highlight2" >*ADAM10↑, "highlight2" >*ADAM10↑, "highlight2" >*ADAM10↑,
102- RES,    Effect of resveratrol on proliferation and apoptosis of human pancreatic cancer MIA PaCa-2 cells may involve inhibition of the Hedgehog signaling pathway
- in-vitro, PC, MIA PaCa-2
"highlight2" >HH↓, "highlight2" >PTCH1↓, "highlight2" >Smo↓, "highlight2" >HH↓, "highlight2" >EMT↓, "highlight2" >PI3K/Akt↓, "highlight2" >NF-kB↓, "highlight2" >TumCP↓, "highlight2" >Apoptosis↑, "highlight2" >ChemoSen↑,
3858- RES,    Alpha-Secretase ADAM10 Regulation: Insights into Alzheimer’s Disease Treatment
- Review, AD, NA
"highlight2" >*neuroP↑, "highlight2" >*antiOx↑, "highlight2" >*LDL↓, "highlight2" >*ADAM10↑,
3056- RES,    Less is more for cancer chemoprevention: evidence of a non-linear dose response for the protective effects of resveratrol in humans and mice
- in-vivo, Nor, NA
"highlight2" >*AMPK↑, "highlight2" >*P21↑, "highlight2" >*Dose↓, "highlight2" >*chemoPv↑,
103- RES,  CUR,  QC,    The effect of resveratrol, curcumin and quercetin combination on immuno-suppression of tumor microenvironment for breast tumor-bearing mice
- vitro+vivo, BC, 4T1
"highlight2" >ROS↑, "highlight2" >MMP↓, "highlight2" >Bcl-2↓, "highlight2" >BAX↑, "highlight2" >Casp9↑, "highlight2" >T-Cell↑, "highlight2" >TGF-β↓,
3614- RES,    Resveratrol--a boon for treating Alzheimer's disease?
- Review, AD, NA
"highlight2" >*SIRT1↑, "highlight2" >*neuroP↑,
3613- RES,    Resveratrol for Alzheimer's disease
- Review, AD, NA
"highlight2" >*SIRT1↑, "highlight2" >*BioAv↝, "highlight2" >*toxicity↓, "highlight2" >*ROS↓, "highlight2" >*antiOx↑, "highlight2" >*Aβ↓, "highlight2" >*MMP9↓, "highlight2" >*TNF-α↓,
3612- RES,    Resveratrol in Alzheimer's disease: a review of pathophysiology and therapeutic potential
- Review, AD, NA
"highlight2" >*other↑, "highlight2" >*Aβ↓, "highlight2" >*Inflam↓, "highlight2" >*NF-kB↓, "highlight2" >*neuroP↑, "highlight2" >*HO-1↑, "highlight2" >*lipid-P↓, "highlight2" >*COX2↓, "highlight2" >*AMPK↑, "highlight2" >*Catalase↑, "highlight2" >*SOD↑, "highlight2" >*GSR↑, "highlight2" >*ROS↓, "highlight2" >*MMP9↓, "highlight2" >*cognitive↑, "highlight2" >*SIRT1↑, "highlight2" >*IL1β↓, "highlight2" >*IL6↓,
3100- RES,    Neuroprotective effects of resveratrol in Alzheimer disease pathology
- Review, AD, NA
"highlight2" >*neuroP↑, "highlight2" >*BioAv↓, "highlight2" >*Half-Life↓, "highlight2" >*BioAv↑, "highlight2" >*BBB↑, "highlight2" >*NRF2↑, "highlight2" >*BioAv↓, "highlight2" >*BioAv↑, "highlight2" >*SIRT1↑, "highlight2" >*cognitive↑, "highlight2" >*lipid-P↓, "highlight2" >*HO-1↑, "highlight2" >*SOD↑, "highlight2" >*GSH↑, "highlight2" >*GPx↑, "highlight2" >*G6PD↑, "highlight2" >*PPARγ↑, "highlight2" >*AMPK↑, "highlight2" >*Aβ↓,
3099- RES,    Resveratrol and cognitive decline: a clinician perspective
- Review, Nor, NA - NA, AD, NA
"highlight2" >*antiOx↑, "highlight2" >*ROS↓, "highlight2" >*cognitive↑, "highlight2" >*neuroP↑, "highlight2" >*SIRT1↑, "highlight2" >*AMPK↑, "highlight2" >*GPx↑, "highlight2" >*HO-1↑, "highlight2" >*GSK‐3β↑, "highlight2" >*COX2↓, "highlight2" >*PGE2↓, "highlight2" >*NF-kB↓, "highlight2" >*NO↓, "highlight2" >*Casp3↓, "highlight2" >*MMP3↓, "highlight2" >*MMP9↓, "highlight2" >*MMP↑, "highlight2" >*GSH↑, "highlight2" >*other↑, "highlight2" >*BioAv↑, "highlight2" >*memory↑, "highlight2" >*GlutMet↑, "highlight2" >*BioAv↓, "highlight2" >*Half-Life↓, "highlight2" >*toxicity∅,
3098- RES,    Regulation of Cell Signaling Pathways and miRNAs by Resveratrol in Different Cancers
- Review, Var, NA
"highlight2" >NOTCH2↓, "highlight2" >Wnt↓, "highlight2" >β-catenin/ZEB1↓, "highlight2" >p‑SMAD2↓, "highlight2" >p‑SMAD3↓, "highlight2" >PTCH1↓, "highlight2" >Smo↓, "highlight2" >Gli1↓, "highlight2" >E-cadherin↑, "highlight2" >NOTCH⇅, "highlight2" >TAC?, "highlight2" >NKG2D↑, "highlight2" >DR4↑, "highlight2" >survivin↓, "highlight2" >DR5↑, "highlight2" >BAX↑, "highlight2" >p27↑, "highlight2" >cycD1/CCND1↓, "highlight2" >Bcl-2↓, "highlight2" >STAT3↓, "highlight2" >STAT5↓, "highlight2" >JAK↓, "highlight2" >DNAdam↑, "highlight2" >γH2AX↑,
3097- RES,    Resveratrol Induces Notch2-mediated Apoptosis and Suppression of Neuroendocrine Markers in Medullary Thyroid Cancer
- in-vitro, Thyroid, TT
"highlight2" >TumCG↓, "highlight2" >cl‑Casp3↑, "highlight2" >p‑PARP↑, "highlight2" >NOTCH2↑,
3096- RES,    Identification of potential target genes of non-small cell lung cancer in response to resveratrol treatment by bioinformatics analysis
- in-vitro, Lung, A549 - in-vitro, Lung, H1299
"highlight2" >TumCP↓, "highlight2" >Apoptosis↑, "highlight2" >Akt↓, "highlight2" >mTOR↓, "highlight2" >p38↑, "highlight2" >MAPK↑, "highlight2" >STAT3↓, "highlight2" >ROS↑, "highlight2" >SIRT1↑, "highlight2" >SOX2↓,
3095- RES,    Resveratrol suppresses migration, invasion and stemness of human breast cancer cells by interfering with tumor-stromal cross-talk
- in-vitro, BC, NA
"highlight2" >TumCP↓, "highlight2" >TumCMig↓, "highlight2" >TumCI↓, "highlight2" >cycD1/CCND1↓, "highlight2" >cMyc↓, "highlight2" >MMP2↓, "highlight2" >MMP9↓, "highlight2" >SOX2↓, "highlight2" >Akt↓, "highlight2" >STAT3↓, "highlight2" >α-SMA↓,
3094- RES,    Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase
- in-vitro, BC, MCF-7 - in-vitro, BC, MDA-MB-231
"highlight2" >CSCs↓, "highlight2" >tumCV↓, "highlight2" >FASN↑, "highlight2" >BNIP3↑, "highlight2" >*cardioP↑, "highlight2" >*antiOx↑, "highlight2" >NF-kB↓, "highlight2" >COX2↓, "highlight2" >MMP9↓, "highlight2" >IGF-1↓, "highlight2" >ERK↓, "highlight2" >lipid-P↓, "highlight2" >CD24↓,
3093- RES,    Pro-Oxidant Effect of Resveratrol on Human Breast Cancer MCF-7 Cells is Associated with CK2 Inhibition
- in-vitro, BC, MCF-7
"highlight2" >ROS↑, "highlight2" >CK2↓,
3092- RES,    Resveratrol in breast cancer treatment: from cellular effects to molecular mechanisms of action
- Review, BC, MDA-MB-231 - Review, BC, MCF-7
"highlight2" >TumCP↓, "highlight2" >tumCV↓, "highlight2" >TumCI↓, "highlight2" >TumMeta↓, "highlight2" >*antiOx↑, "highlight2" >*cardioP↑, "highlight2" >*Inflam↓, "highlight2" >*neuroP↑, "highlight2" >*Keap1↓, "highlight2" >*NRF2↑, "highlight2" >*ROS↓, "highlight2" >p62↓, "highlight2" >IL1β↓, "highlight2" >CRP↓, "highlight2" >VEGF↓, "highlight2" >Bcl-2↓, "highlight2" >MMP2↓, "highlight2" >MMP9↓, "highlight2" >FOXO4↓, "highlight2" >POLD1↓, "highlight2" >CK2↓, "highlight2" >MMP↓, "highlight2" >ROS↑, "highlight2" >Apoptosis↑, "highlight2" >TumCCA↑, "highlight2" >Beclin-1↓, "highlight2" >Ki-67↓, "highlight2" >ATP↓, "highlight2" >GlutMet↓, "highlight2" >PFK↓, "highlight2" >TGF-β↓, "highlight2" >SMAD2↓, "highlight2" >SMAD3↓, "highlight2" >Vim?, "highlight2" >Snail↓, "highlight2" >Slug↓, "highlight2" >E-cadherin↑, "highlight2" >EMT↓, "highlight2" >Zeb1↓, "highlight2" >Fibronectin↓, "highlight2" >IGF-1↓, "highlight2" >PI3K↓, "highlight2" >Akt↓, "highlight2" >HO-1↑, "highlight2" >eff↑, "highlight2" >PD-1↓, "highlight2" >CD8+↑, "highlight2" >Th1 response↑, "highlight2" >CSCs↓, "highlight2" >RadioS↑, "highlight2" >SIRT1↑, "highlight2" >Hif1a↓, "highlight2" >mTOR↓,
3091- RES,    Protein kinase CK2 modulates apoptosis induced by resveratrol and epigallocatechin-3-gallate in prostate cancer cells
- in-vitro, Pca, PC3 - in-vitro, Pca, ALVA-41
"highlight2" >CK2↓, "highlight2" >Apoptosis↑,
3090- RES,    The Effects of Resveratrol Targeting MicroRNA-4325P/PDGF-B to Regulate Tumor Angiogenesis in Osteosarcoma Microenvironment
- in-vitro, OS, MG63
"highlight2" >PDGFR-BB↓, "highlight2" >angioG↓,
1489- RES,    Molecular mechanisms of resveratrol as chemo and radiosensitizer in cancer
- Review, Var, NA
"highlight2" >RadioS↑, "highlight2" >ChemoSen↑, "highlight2" >*BioAv↓, "highlight2" >*BioAv↑, "highlight2" >Ferroptosis↑, "highlight2" >lipid-P↑, "highlight2" >xCT↓, "highlight2" >GPx4↓, "highlight2" >*BioAv↑, "highlight2" >COX2↓, "highlight2" >cycD1/CCND1↓, "highlight2" >FasL↓, "highlight2" >FOXP3↓, "highlight2" >HLA↑, "highlight2" >p‑NF-kB↓, "highlight2" >BAX↑, "highlight2" >Bcl-2↓, "highlight2" >MALAT1↓,
877- RES,    Resveratrol Inhibits Invasion and Metastasis of Colorectal Cancer Cells via MALAT1 Mediated Wnt/β-Catenin Signal Pathway
- in-vitro, CRC, LoVo - in-vitro, CRC, HCT116
"highlight2" >MALAT1↓, "highlight2" >Wnt/(β-catenin)↓, "highlight2" >TumCI↓, "highlight2" >TumMeta↓,
2334- RES,    Glut 1 in Cancer Cells and the Inhibitory Action of Resveratrol as A Potential Therapeutic Strategy
- Review, Var, NA
"highlight2" >GLUT1↓, "highlight2" >GlucoseCon↓, "highlight2" >lactateProd↓, "highlight2" >Akt↓, "highlight2" >mTOR↓, "highlight2" >Dose↝, "highlight2" >SIRT6↑, "highlight2" >PKM2↓, "highlight2" >HK2↓, "highlight2" >PFK1↓, "highlight2" >ChemoSen↑,
2333- RES,    Resveratrol regulates insulin resistance to improve the glycolytic pathway by activating SIRT2 in PCOS granulosa cells
- in-vitro, Nor, NA
"highlight2" >*glucose↓, "highlight2" >*Insulin↓, "highlight2" >*IGFR↓, "highlight2" >*IGF-1↓, "highlight2" >*LDHA↑, "highlight2" >*HK2↑, "highlight2" >*PKM2↑, "highlight2" >*Glycolysis↝, "highlight2" >*SIRT2↑,
2332- RES,    Resveratrol’s Anti-Cancer Effects through the Modulation of Tumor Glucose Metabolism
- Review, Var, NA
"highlight2" >Glycolysis↓, "highlight2" >GLUT1↓, "highlight2" >PFK1↓, "highlight2" >Hif1a↓, "highlight2" >ROS↑, "highlight2" >PDH↑, "highlight2" >AMPK↑, "highlight2" >TumCG↓, "highlight2" >TumCI↓, "highlight2" >TumCP↓, "highlight2" >p‑NF-kB↓, "highlight2" >SIRT1↑, "highlight2" >SIRT3↑, "highlight2" >LDH↓, "highlight2" >PI3K↓, "highlight2" >mTOR↓, "highlight2" >PKM2↓, "highlight2" >R5P↝, "highlight2" >G6PD↓, "highlight2" >TKT↝, "highlight2" >talin↓, "highlight2" >HK2↓, "highlight2" >GRP78/BiP↑, "highlight2" >GlucoseCon↓, "highlight2" >ER Stress↑, "highlight2" >Warburg↓, "highlight2" >PFK↓,
2331- RES,    Resveratrol improves follicular development of PCOS rats via regulating glycolysis pathway and targeting SIRT1
- in-vivo, Nor, NA
"highlight2" >*LDHA↑, "highlight2" >*PKM2↑, "highlight2" >*SIRT1↑, "highlight2" >*Glycolysis↝,
2330- RES,    Resveratrol Induces Cancer Cell Apoptosis through MiR-326/PKM2-Mediated ER Stress and Mitochondrial Fission
- in-vitro, CRC, DLD1 - in-vitro, Cerv, HeLa - in-vitro, BC, MCF-7
"highlight2" >TumCP↓, "highlight2" >Apoptosis↑, "highlight2" >PKM2↓, "highlight2" >ER Stress↑,
2329- RES,    Resveratrol induces apoptosis in human melanoma cell through negatively regulating Erk/PKM2/Bcl-2 axis
- in-vitro, Melanoma, A375
"highlight2" >P53↑, "highlight2" >Bcl-2↓, "highlight2" >BAX↑, "highlight2" >Cyt‑c↑, "highlight2" >ERK↓, "highlight2" >PKM2↓, "highlight2" >Apoptosis↑, "highlight2" >γH2AX↑, "highlight2" >Casp3↑, "highlight2" >cl‑PARP1↑,
2328- RES,    Resveratrol Inhibits Cancer Cell Metabolism by Down Regulating Pyruvate Kinase M2 via Inhibition of Mammalian Target of Rapamycin
- in-vitro, Cerv, HeLa - in-vitro, Liver, HepG2 - in-vitro, BC, MCF-7
"highlight2" >PKM2↓, "highlight2" >mTOR↓, "highlight2" >GlucoseCon↓, "highlight2" >lactateProd↓,
105- RES,  QC,    The Effect of Resveratrol and Quercetin on Epithelial-Mesenchymal Transition in Pancreatic Cancer Stem Cell
- in-vitro, Pca, PANC1
"highlight2" >N-cadherin↓, "highlight2" >TNF-α↓, "highlight2" >ACTA2↓, "highlight2" >EMT↓, "highlight2" >CD133↓, "highlight2" >CSCs↓,
871- RES,  CUR,  QC,    The effect of resveratrol, curcumin and quercetin combination on immuno-suppression of tumor microenvironment for breast tumor-bearing mice
- in-vitro, BC, 4T1 - in-vivo, BC, 4T1
"highlight2" >T-Cell↑, "highlight2" >Neut↓, "highlight2" >Macrophages↓, "highlight2" >ROS↑, "highlight2" >MMP↓, "highlight2" >other↓, "highlight2" >AntiTum↑, "highlight2" >TumVol↓,
1511- RES,  Chemo,    Combination therapy in combating cancer
- Review, NA, NA
"highlight2" >eff↑, "highlight2" >*NRF2↑, "highlight2" >*GSH↑, "highlight2" >*ROS↓, "highlight2" >chemoPv↑, "highlight2" >ChemoSideEff↓,
1506- RES,    Epigenetic targets of bioactive dietary components for cancer prevention and therapy
- Review, NA, NA
"highlight2" >DNMTs↓, "highlight2" >BRCA1↑, "highlight2" >HDAC↓, "highlight2" >SIRT1↑, "highlight2" >p300↓, "highlight2" >survivin↓, "highlight2" >HDAC1↓, "highlight2" >HDAC3↓, "highlight2" >HDAC8↓,
1492- RES,    Resveratrol: Biological and pharmaceutical properties as anticancer molecule
- Review, Var, NA
"highlight2" >RadioS↑, "highlight2" >ChemoSen↑,
1491- RES,    Resveratrol Augments Doxorubicin and Cisplatin Chemotherapy: A Novel Therapeutic Strategy
"highlight2" >RadioS↑, "highlight2" >ChemoSen↑,
1490- RES,    Anticancer Potential of Resveratrol, β-Lapachone and Their Analogues
- Review, Var, NA
"highlight2" >TumCCA↑, "highlight2" >ROS↑, "highlight2" >Ca+2↑, "highlight2" >MMP↓, "highlight2" >ATP↓, "highlight2" >TOP1?, "highlight2" >P53↑, "highlight2" >p53 Wildtype∅, "highlight2" >Akt↓, "highlight2" >mTOR↓, "highlight2" >EMT↓, "highlight2" >*BioAv↓,
2439- RES,    By reducing hexokinase 2, resveratrol induces apoptosis in HCC cells addicted to aerobic glycolysis and inhibits tumor growth in mice
- in-vitro, HCC, HCCLM3 - in-vitro, Nor, L02 - in-vitro, HCC, SMMC-7721 cell - in-vitro, HCC, Bel-7402 - in-vitro, HCC, HUH7
"highlight2" >HK2↓, "highlight2" >ChemoSen↑, "highlight2" >other↑, "highlight2" >Glycolysis↓, "highlight2" >lactateProd↓, "highlight2" >TumCP↓, "highlight2" >Casp3↑, "highlight2" >cl‑PARP↑, "highlight2" >PKM2↓,
1391- RES,  BBR,    Effects of Resveratrol, Berberine and Their Combinations on Reactive Oxygen Species, Survival and Apoptosis in Human Squamous Carcinoma (SCC-25) Cells
- in-vitro, Tong, SCC25
"highlight2" >ROS↑, "highlight2" >eff↑,
1282- RES,    Resveratrol Inhibits CD4+ T Cell Activation by Enhancing the Expression and Activity of Sirt1
- vitro+vivo, NA, NA
"highlight2" >T-Cell↓, "highlight2" >SIRT1↑, "highlight2" >CD4+↓,
1047- RES,    Resveratrol induces PD-L1 expression through snail-driven activation of Wnt pathway in lung cancer cells
- in-vitro, Lung, H1299 - in-vitro, Lung, A549 - in-vitro, Lung, H460
"highlight2" >PD-L1↑, "highlight2" >Snail↑, "highlight2" >E-cadherin↓, "highlight2" >N-cadherin↑, "highlight2" >Fibronectin↑, "highlight2" >Vim↑, "highlight2" >Axin2↓,
993- RES,    Resveratrol reverses the Warburg effect by targeting the pyruvate dehydrogenase complex in colon cancer cells
- in-vitro, CRC, Caco-2 - in-vivo, Nor, HCEC 1CT
"highlight2" >TumCG↓, "highlight2" >Glycolysis↓, "highlight2" >PPP↓, "highlight2" >ATP↑, "highlight2" >PDH↑, "highlight2" >Ca+2↝, "highlight2" >TumCP↓, "highlight2" >lactateProd↓, "highlight2" >OCR↑, "highlight2" >ECAR↓, "highlight2" >*ECAR∅, "highlight2" >*other?, "highlight2" >cycE/CCNE↑, "highlight2" >cycA1/CCNA1↑, "highlight2" >TumCCA↑, "highlight2" >cycD1/CCND1↑, "highlight2" >OXPHOS↑,
967- RES,    Resveratrol binds and inhibits transcription factor HIF-1α in pancreatic cancer
- Analysis, PC, NA
"highlight2" >Hif1a↓,
924- RES,    Resveratrol sequentially induces replication and oxidative stresses to drive p53-CXCR2 mediated cellular senescence in cancer cells
- in-vitro, OS, U2OS - in-vitro, Lung, A549
"highlight2" >TumCCA↑, "highlight2" >ROS↑, "highlight2" >γH2AX↑, "highlight2" >ATM↑, "highlight2" >p‑CHK1↑, "highlight2" >cellSen↑, "highlight2" >CXCR2↑,
885- RES,    Resveratrol induces intracellular Ca2 + rise via T-type Ca2 + channels in a mesothelioma cell line
- in-vitro, RCC, REN - in-vitro, Nor, MeT5A
"highlight2" >TumCG↓, "highlight2" >Ca+2↑, "highlight2" >*toxicity↓,
884- RES,  PTS,    Resveratrol and Pterostilbene Exhibit Anticancer Properties Involving the Downregulation of HPV Oncoprotein E6 in Cervical Cancer Cells
- in-vitro, Cerv, HeLa
"highlight2" >TumCD↑, "highlight2" >TumCCA↑, "highlight2" >E6↓, "highlight2" >Casp3↑, "highlight2" >P53↑,
883- RES,    Targeting Histone Deacetylases with Natural and Synthetic Agents: An Emerging Anticancer Strategy
"highlight2" >HDAC↓, "highlight2" >TumCCA↑, "highlight2" >Apoptosis↑, "highlight2" >angioG↓, "highlight2" >ROS↑,
882- RES,    Resveratrol: A Double-Edged Sword in Health Benefits
- Review, NA, NA
"highlight2" >AntiTum↑, "highlight2" >Casp3↑, "highlight2" >Casp9↑, "highlight2" >BAX↑, "highlight2" >Bcl-2↓, "highlight2" >Bcl-xL↓, "highlight2" >P53↑, "highlight2" >NAF1↓, "highlight2" >NRF2↑, "highlight2" >ROS↑, "highlight2" >Apoptosis↑, "highlight2" >HDAC↓, "highlight2" >TumCCA↑, "highlight2" >TumAuto↑, "highlight2" >angioG↓, "highlight2" >iNOS↓,
881- RES,    Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein
- in-vitro, BC, MDA-MB-231 - in-vitro, PC, PANC1 - in-vitro, Pca, DU145
"highlight2" >TumCCA↑, "highlight2" >cycD1/CCND1↓, "highlight2" >Bcl-xL↓, "highlight2" >Mcl-1↓, "highlight2" >other↓,
880- RES,    Forkhead Proteins Are Critical for Bone Morphogenetic Protein-2 Regulation and Anti-tumor Activity of Resveratrol
- in-vitro, BC, MDA-MB-231
"highlight2" >other↓, "highlight2" >TumW↓, "highlight2" >FOXO↑, "highlight2" >BMP2↑,
879- RES,    Evidence that TNF-β induces proliferation in colorectal cancer cells and resveratrol can down-modulate it
- in-vitro, CRC, HCT116
"highlight2" >TumCP↓, "highlight2" >NF-kB↓,
878- RES,    Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression
- vitro+vivo, CRC, LoVo
"highlight2" >TumMeta↓, "highlight2" >E-cadherin↑, "highlight2" >Vim↓, "highlight2" >TGF-β↓, "highlight2" >SMAD2↓, "highlight2" >EMT↓, "highlight2" >SMAD3↓,
2981- RES,    Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways
- in-vitro, Colon, HT-29 - in-vitro, Colon, SW48
"highlight2" >TumCCA↑, "highlight2" >p27↑, "highlight2" >cycD1/CCND1↓, "highlight2" >TumCP↓, "highlight2" >IGF-1R↓, "highlight2" >Akt↓, "highlight2" >Wnt↓, "highlight2" >P53↑, "highlight2" >Apoptosis↑, "highlight2" >Sp1/3/4↓, "highlight2" >cl‑PARP↑, "highlight2" >β-catenin/ZEB1↓, "highlight2" >MDM2↓,
3055- RES,    Resveratrol and Tumor Microenvironment: Mechanistic Basis and Therapeutic Targets
- Review, Var, NA
"highlight2" >BioAv↓, "highlight2" >BioAv↓, "highlight2" >Dose↑, "highlight2" >eff↑, "highlight2" >eff↑, "highlight2" >Dose↑, "highlight2" >BioAv↑, "highlight2" >ROS↑, "highlight2" >MMP↓, "highlight2" >P21↑, "highlight2" >p27↑, "highlight2" >TumCCA↑, "highlight2" >ChemoSen↑, "highlight2" >COX2↓, "highlight2" >5LO↓, "highlight2" >VEGF↓, "highlight2" >IL1↓, "highlight2" >IL6↓, "highlight2" >IL8↓, "highlight2" >AR↓, "highlight2" >PSA↓, "highlight2" >MAPK↓, "highlight2" >Hif1a↓, "highlight2" >Glycolysis↓, "highlight2" >miR-21↓, "highlight2" >PTEN↑, "highlight2" >Half-Life↝, "highlight2" >*IGF-1↓, "highlight2" >*IGFBP3↑, "highlight2" >Half-Life↓,
3054- RES,    Resveratrol induced reactive oxygen species and endoplasmic reticulum stress-mediated apoptosis, and cell cycle arrest in the A375SM malignant melanoma cell line
- in-vitro, Melanoma, A375
"highlight2" >TumCG↓, "highlight2" >P21↑, "highlight2" >p27↑, "highlight2" >CycB/CCNB1↓, "highlight2" >ROS↑, "highlight2" >ER Stress↑, "highlight2" >p‑p38↑, "highlight2" >P53↑, "highlight2" >p‑eIF2α↑, "highlight2" >EP4↑, "highlight2" >CHOP↑, "highlight2" >Bcl-2↓, "highlight2" >BAX↓, "highlight2" >TumCCA↑, "highlight2" >NRF2↓, "highlight2" >ChemoSen↑, "highlight2" >GSH↓,
3053- RES,    Resveratrol represses estrogen-induced mammary carcinogenesis through NRF2-UGT1A8-estrogen metabolic axis activation
- in-vitro, NA, NA
"highlight2" >NRF2↑, "highlight2" >DNAdam↓,
3052- RES,    Resveratrol-Induced Downregulation of NAF-1 Enhances the Sensitivity of Pancreatic Cancer Cells to Gemcitabine via the ROS/Nrf2 Signaling Pathways
- in-vitro, PC, PANC1 - in-vitro, PC, MIA PaCa-2 - in-vitro, PC, Bxpc-3
"highlight2" >NAF1↓, "highlight2" >ROS↑, "highlight2" >NRF2↑, "highlight2" >eff↑, "highlight2" >TumCG↓,
2991- RES,  Chemo,    Synergistic anti-cancer effects of resveratrol and chemotherapeutic agent clofarabine against human malignant mesothelioma MSTO-211H cells
- in-vitro, Melanoma, MSTO-211H - in-vitro, Nor, MeT5A
"highlight2" >eff↑, "highlight2" >selectivity↑, "highlight2" >Sp1/3/4↓,
2990- RES,    Resveratrol reduces cerebral edema through inhibition of de novo SUR1 expression induced after focal ischemia
- in-vivo, Stroke, NA
"highlight2" >*OS↑, "highlight2" >*antiOx↑, "highlight2" >Sp1/3/4↓,
2989- RES,    Resveratrol Represses Pokemon Expression in Human Glioma Cells
- in-vitro, GBM, NA
"highlight2" >FBI-1↓, "highlight2" >Sp1/3/4↓,
2988- RES,    The Antimetastatic Effects of Resveratrol on Hepatocellular Carcinoma through the Downregulation of a Metastasis-Associated Protease by SP-1 Modulation
- in-vitro, HCC, HUH7
"highlight2" >TumCMig↓, "highlight2" >TumCI↓, "highlight2" >uPA↓, "highlight2" >Sp1/3/4↓,
2987- RES,    Resveratrol ameliorates myocardial damage by inducing vascular endothelial growth factor-angiogenesis and tyrosine kinase receptor Flk-1
- in-vivo, Nor, NA
"highlight2" >*VEGF↑, "highlight2" >*iNOS↑, "highlight2" >*NF-kB↑, "highlight2" >*Sp1/3/4↑, "highlight2" >*cardioP↑,
2986- RES,    Effect of the natural compound trans‑resveratrol on human MCM4 gene transcription
- in-vitro, Cerv, HeLa - in-vitro, AML, HL-60
"highlight2" >Sp1/3/4↑,
2985- RES,    Resveratrol Inhibits Diabetic-Induced Müller Cells Apoptosis through MicroRNA-29b/Specificity Protein 1 Pathway
- in-vivo, Nor, NA - vitro+vivo, Diabetic, NA
"highlight2" >*Sp1/3/4↓, "highlight2" >*miR-29b↑,
2984- RES,    Involvement of miR-539-5p in the inhibition of de novo lipogenesis induced by resveratrol in white adipose tissue
- in-vivo, Nor, NA
"highlight2" >*Sp1/3/4↓, "highlight2" >*SREBP1↓, "highlight2" >*FASN↓,
2983- RES,    Resveratrol Improves Diabetic Retinopathy via Regulating MicroRNA-29b/Specificity Protein 1/Apoptosis Pathway by Enhancing Autophagy
- in-vitro, Nor, NA
"highlight2" >*Beclin-1↑, "highlight2" >*p62↓, "highlight2" >*Sp1/3/4↓, "highlight2" >*Apoptosis↓,
2982- RES,    The flavonoid resveratrol suppresses growth of human malignant pleural mesothelioma cells through direct inhibition of specificity protein 1
- in-vitro, Melanoma, MSTO-211H
"highlight2" >tumCV↓, "highlight2" >Apoptosis↑, "highlight2" >Sp1/3/4↓, "highlight2" >p27↓, "highlight2" >P21↓, "highlight2" >cycD1/CCND1↓, "highlight2" >Mcl-1↓, "highlight2" >survivin↓,
2440- RES,    Resveratrol inhibits Hexokinases II mediated glycolysis in non-small cell lung cancer via targeting Akt signaling pathway
- in-vitro, Lung, H460 - in-vivo, Lung, NA - in-vitro, Lung, H1650 - in-vitro, Lung, HCC827
"highlight2" >AntiTum↑, "highlight2" >Glycolysis↓, "highlight2" >HK2↓, "highlight2" >EGFR↓, "highlight2" >Akt↓, "highlight2" >ERK↓, "highlight2" >GlucoseCon↓, "highlight2" >lactateProd↓, "highlight2" >TumCG↓, "highlight2" >Ki-67↓,
2565- RES,    https://onlinelibrary.wiley.com/doi/10.1111/j.1365-2141.2007.06788.x
- in-vitro, NA, NA - in-vivo, NA, NA
"highlight2" >AntiAg↑, "highlight2" >TXA2↑, "highlight2" >PKCδ↑, "highlight2" >Dose↝,
2441- RES,    Anti-Cancer Properties of Resveratrol: A Focus on Its Impact on Mitochondrial Functions
- Review, Var, NA
"highlight2" >*toxicity↓, "highlight2" >*BioAv↝, "highlight2" >*Dose↝, "highlight2" >*hepatoP↑, "highlight2" >*neuroP↑, "highlight2" >*AntiAg↑, "highlight2" >*COX2↓, "highlight2" >*antiOx↑, "highlight2" >*ROS↓, "highlight2" >*ROS↑, "highlight2" >PI3K↓, "highlight2" >Akt↓, "highlight2" >NF-kB↓, "highlight2" >Wnt↓, "highlight2" >β-catenin/ZEB1↓, "highlight2" >NRF2↑, "highlight2" >GPx↑, "highlight2" >HO-1↑, "highlight2" >BioEnh?, "highlight2" >PTEN↑, "highlight2" >ChemoSen↑, "highlight2" >eff↑, "highlight2" >mt-ROS↑, "highlight2" >Warburg↓, "highlight2" >Glycolysis↓, "highlight2" >GlucoseCon↓, "highlight2" >GLUT1↓, "highlight2" >lactateProd↓, "highlight2" >HK2↓, "highlight2" >EGFR↓, "highlight2" >cMyc↓, "highlight2" >ROS↝, "highlight2" >MMPs↓, "highlight2" >MMP7↓, "highlight2" >survivin↓, "highlight2" >TumCP↓, "highlight2" >TumCMig↓, "highlight2" >TumCI↓,
2442- RES,    High absorption but very low bioavailability of oral resveratrol in humans
- in-vitro, Nor, NA
"highlight2" >BioAv↝, "highlight2" >Half-Life↝, "highlight2" >BioAv↓, "highlight2" >eff↝,
2443- RES,    Health Benefits and Molecular Mechanisms of Resveratrol: A Narrative Review
- Review, Var, NA
"highlight2" >*antiOx↑, "highlight2" >*ROS↓, "highlight2" >*PTEN↑, "highlight2" >*Akt↓, "highlight2" >*Catalase↑, "highlight2" >*SOD↑, "highlight2" >*ERK↓, "highlight2" >*GSH↑, "highlight2" >*AMPK↑, "highlight2" >*FOXO1↝, "highlight2" >*RNS↓, "highlight2" >*Catalase↑, "highlight2" >*cardioP↑, "highlight2" >*PI3K↑, "highlight2" >*eNOS↑, "highlight2" >hepatoP↑,
2467- RES,    Resveratrol inhibits Ca2+ signals and aggregation of platelets
- in-vitro, Nor, NA
"highlight2" >*AntiAg↑, "highlight2" >Ca+2↓,
2471- RES,    Resveratrol Regulates Glucose and Lipid Metabolism in Diabetic Rats by Inhibition of PDK1/AKT Phosphorylation and HIF-1α Expression
- in-vivo, Diabetic, NA
"highlight2" >*p‑PDK1↓, "highlight2" >*p‑Akt↓, "highlight2" >*Hif1a↓, "highlight2" >*GLUT1↓,
2472- RES,    Resveratrol Restores Sirtuin 1 (SIRT1) Activity and Pyruvate Dehydrogenase Kinase 1 (PDK1) Expression after Hemorrhagic Injury in a Rat Model
- in-vivo, Nor, NA
"highlight2" >*SIRT1↑, "highlight2" >*PGC-1α↑, "highlight2" >*cMyc↑, "highlight2" >*PDK1↓,
2564- RES,    Effect of resveratrol on platelet aggregation by fibrinogen protection
- in-vitro, NA, NA
"highlight2" >AntiAg↑, "highlight2" >antiOx↓, "highlight2" >COX2↓,
2687- RES,    Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs
- Review, NA, NA - Review, AD, NA
"highlight2" >NF-kB↓, "highlight2" >P450↓, "highlight2" >COX2↓, "highlight2" >Hif1a↓, "highlight2" >VEGF↓, "highlight2" >*SIRT1↑, "highlight2" >SIRT1↓, "highlight2" >SIRT2↓, "highlight2" >ChemoSen⇅, "highlight2" >cardioP↑, "highlight2" >*memory↑, "highlight2" >*angioG↑, "highlight2" >*neuroP↑, "highlight2" >STAT3↓, "highlight2" >CSCs↓, "highlight2" >RadioS↑, "highlight2" >Nestin↓, "highlight2" >Nanog↓, "highlight2" >TP53↑, "highlight2" >P21↑, "highlight2" >CXCR4↓, "highlight2" >*BioAv↓, "highlight2" >EMT↓, "highlight2" >Vim↓, "highlight2" >Slug↓, "highlight2" >E-cadherin↑, "highlight2" >AMPK↑, "highlight2" >MDR1↓, "highlight2" >DNAdam↑, "highlight2" >TOP2↓, "highlight2" >PTEN↑, "highlight2" >Akt↓, "highlight2" >Wnt↓, "highlight2" >β-catenin/ZEB1↓, "highlight2" >cMyc↓, "highlight2" >MMP7↓, "highlight2" >MALAT1↓, "highlight2" >TCF↓, "highlight2" >ALDH↓, "highlight2" >CD44↓, "highlight2" >Shh↓, "highlight2" >IL6↓, "highlight2" >VEGF↓, "highlight2" >eff↑, "highlight2" >HK2↓, "highlight2" >ROS↑, "highlight2" >MMP↓,
2566- RES,    A comprehensive review on the neuroprotective potential of resveratrol in ischemic stroke
- Review, Stroke, NA
"highlight2" >*neuroP↑, "highlight2" >*NRF2↑, "highlight2" >*SIRT1↑, "highlight2" >*PGC-1α↑, "highlight2" >*FOXO↑, "highlight2" >*HO-1↑, "highlight2" >*NQO1↑, "highlight2" >*ROS↓, "highlight2" >*BP↓, "highlight2" >*BioAv↓, "highlight2" >*Half-Life↝, "highlight2" >*AMPK↑, "highlight2" >*GSK‐3β↓, "highlight2" >*eff↑, "highlight2" >*AntiAg↑, "highlight2" >*BBB↓, "highlight2" >*Inflam↓, "highlight2" >*MPO↓, "highlight2" >*TLR4↓, "highlight2" >*NF-kB↓, "highlight2" >*p65↓, "highlight2" >*MMP9↓, "highlight2" >*TNF-α↓, "highlight2" >*IL1β↓, "highlight2" >*PPARγ↑, "highlight2" >*MMP↑, "highlight2" >*ATP↑, "highlight2" >*Cyt‑c∅, "highlight2" >*mt-lipid-P↓, "highlight2" >*H2O2↓, "highlight2" >*HSP70/HSPA5↝, "highlight2" >*Mets↝, "highlight2" >*eff↑, "highlight2" >*eff↑, "highlight2" >*motorD↑, "highlight2" >*MDA↓, "highlight2" >*NADH:NAD↑, "highlight2" >eff↑, "highlight2" >eff↑,
2567- RES,    Neuroprotective Effects of Resveratrol in Ischemic Brain Injury
- Review, Stroke, NA
"highlight2" >*eff↑, "highlight2" >*neuroP↑, "highlight2" >*antiOx↑, "highlight2" >*Inflam↓, "highlight2" >*cardioP↑, "highlight2" >*AntiAg↑,
2568- RES,    Resveratrol: A Miracle Drug for Vascular Pathologies
- Review, Var, NA
"highlight2" >antiOx↑, "highlight2" >Inflam↓, "highlight2" >cardioP↑,
104- RES,  QC,    Resveratrol and Quercetin in Combination Have Anticancer Activity in Colon Cancer Cells and Repress Oncogenic microRNA-27a
- in-vitro, Colon, HT-29
"highlight2" >Casp3↑, "highlight2" >PARP↑, "highlight2" >survivin↓, "highlight2" >miR-27a-3p↓, "highlight2" >Sp1/3/4↓, "highlight2" >ZBTB10↑, "highlight2" >ROS⇅, "highlight2" >TAC↑, "highlight2" >tumCV↓,
2650- RES,    Oxidative Stress Inducers in Cancer Therapy: Preclinical and Clinical Evidence
- Review, Var, NA
"highlight2" >ROS↑, "highlight2" >Dose↝, "highlight2" >NRF2↑, "highlight2" >NAF1↓, "highlight2" >ChemoSen↑, "highlight2" >BioAv↓,
4666- RES,    Structural modification of resveratrol analogue exhibits anticancer activity against lung cancer stem cells via suppression of Akt signaling pathway
- in-vitro, Lung, H23 - in-vitro, Lung, H292 - in-vitro, Lung, A549
"highlight2" >CSCs↓, "highlight2" >eff↑, "highlight2" >Akt↓, "highlight2" >GSK‐3β↑, "highlight2" >SOX2↓, "highlight2" >cMyc↓, "highlight2" >TumCCA↑, "highlight2" >ROS↑, "highlight2" >Apoptosis↑,
4667- RES,  CUR,  SFN,    Physiological modulation of cancer stem cells by natural compounds: Insights from preclinical models
- Review, Var, NA
"highlight2" >CSCs↓, "highlight2" >ChemoSen↑, "highlight2" >RadioS↑, "highlight2" >ALDH↓, "highlight2" >CD44↓, "highlight2" >Wnt↓, "highlight2" >β-catenin/ZEB1↓, "highlight2" >NOTCH↓, "highlight2" >HH↓, "highlight2" >NF-kB↓,
4668- RES,    Resveratrol Impedes the Stemness, Epithelial-Mesenchymal Transition, and Metabolic Reprogramming of Cancer Stem Cells in Nasopharyngeal Carcinoma through p53 Activation
- in-vitro, NPC, NA
"highlight2" >ROS↑, "highlight2" >MMP↓, "highlight2" >CSCs↓, "highlight2" >P53↑, "highlight2" >EMT↓,
4669- RES,    Inhibition of RAD51 by siRNA and Resveratrol Sensitizes Cancer Stem Cells Derived from HeLa Cell Cultures to Apoptosis
- in-vitro, Cerv, NA
"highlight2" >RAD51↓, "highlight2" >CSCs↓,
4670- RES,  CUR,  EGCG,  TQ,    Targeting aging pathways with natural compounds: a review of curcumin, epigallocatechin gallate, thymoquinone, and resveratrol
- Review, Nor, NA
"highlight2" >*antiOx↑, "highlight2" >*Inflam↓, "highlight2" >*AntiAge↑, "highlight2" >*SIRT1↑, "highlight2" >*SIRT3↑, "highlight2" >*FOXO↑, "highlight2" >*ROS↓,
4706- RES,    Resveratrol as a circadian clock modulator: mechanisms of action and therapeutic applications
- Review, Nor, NA
"highlight2" >*SIRT1↑, "highlight2" >*CLOCK↝,
3034- RosA,  RES,  Ba,    The effect of dietary polyphenols on the epigenetic regulation of gene expression in MCF7 breast cancer cells
- in-vitro, BC, MCF-7
"highlight2" >DNMTs↓, "highlight2" >eff↑, "highlight2" >eff↝,
2306- SIL,  CUR,  RES,  EA,    Identification of Natural Compounds as Inhibitors of Pyruvate Kinase M2 for Cancer Treatment
- in-vitro, BC, MDA-MB-231
"highlight2" >PKM2↓, "highlight2" >Dose↝, "highlight2" >Dose↝,
119- UA,  CUR,  RES,    Combinatorial treatment with natural compounds in prostate cancer inhibits prostate tumor growth and leads to key modulations of cancer cell metabolism
- in-vitro, Pca, DU145 - in-vitro, Pca, PC3
"highlight2" >ROS⇅, "highlight2" >p‑STAT3↓, "highlight2" >Src↓, "highlight2" >AMPK↑, "highlight2" >GlutMet↑, "highlight2" >TCA↑, "highlight2" >glut↓,
3921- VitD3,  RES,    Vitamin D Combined with Resveratrol Prevents Cognitive Decline in SAMP8 Mice
- in-vivo, AD, NA
"highlight2" >*cognitive↑, "highlight2" >*Aβ↓, "highlight2" >*BACE↓, "highlight2" >*p‑tau↓, "highlight2" >*p‑CREB↑, "highlight2" >*p‑NF-kB↓, "highlight2" >*neuroP↑,

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 157

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress ⓘ

antiOx↓, 1,   antiOx↑, 1,   ATF3↑, 1,   Catalase↓, 1,   Ferroptosis↑, 1,   GPx↑, 1,   GPx4↓, 1,   GSH↓, 1,   GSH↑, 1,   GSTs↑, 1,   H2O2↑, 1,   HO-1↓, 1,   HO-1↑, 2,   lipid-P↓, 2,   lipid-P↑, 1,   NAF1↓, 3,   NRF2↓, 1,   NRF2↑, 7,   OXPHOS↓, 1,   OXPHOS↑, 1,   Prx↓, 1,   ROS↓, 3,   ROS↑, 26,   ROS⇅, 2,   ROS↝, 1,   mt-ROS↑, 1,   SIRT3↑, 1,   SOD↑, 1,   SOD2↓, 1,   TAC?, 1,   TAC↑, 1,   TKT↝, 1,   Trx↓, 1,   Trx1↓, 1,   xCT↓, 1,  

Mitochondria & Bioenergetics ⓘ

ATP↓, 2,   ATP↑, 1,   MKP5↑, 1,   MMP↓, 8,   OCR↑, 1,   XIAP↓, 2,  

Core Metabolism/Glycolysis ⓘ

AMPK↑, 4,   cMyc↓, 7,   ECAR↓, 1,   FASN↑, 1,   FBI-1↓, 1,   FDG↓, 1,   G6PD↓, 1,   glucose↓, 1,   GlucoseCon↓, 6,   glut↓, 1,   GlutMet↓, 1,   GlutMet↑, 1,   Glycolysis↓, 6,   HK2↓, 6,   lactateProd↓, 7,   LDH↓, 1,   NADPH↑, 1,   PDH↑, 2,   PFK↓, 2,   PFK1↓, 2,   PI3K/Akt↓, 1,   PKM2↓, 7,   POLD1↓, 1,   PPP↓, 1,   R5P↝, 1,   SIRT1↓, 1,   SIRT1↑, 12,   SIRT2↓, 1,   TCA↑, 1,   Warburg↓, 2,  

Cell Death ⓘ

AhR↓, 1,   Akt↓, 14,   p‑Akt↓, 1,   Apoptosis↑, 19,   BAX↓, 1,   BAX↑, 7,   Bcl-2↓, 9,   Bcl-xL↓, 3,   BIM↑, 1,   BMP2↑, 1,   Casp3↑, 8,   cl‑Casp3↑, 1,   Casp9↑, 4,   CK2↓, 3,   Cyt‑c↑, 4,   Diablo↑, 1,   DR4↑, 2,   DR5↑, 2,   FasL↓, 1,   Ferroptosis↑, 1,   GADD34↑, 1,   iNOS↓, 1,   p‑JNK↓, 2,   MAPK↓, 2,   MAPK↑, 2,   Mcl-1↓, 2,   MDM2↓, 1,   necrosis↑, 1,   p27↓, 1,   p27↑, 5,   p38↓, 1,   p38↑, 1,   p‑p38↑, 2,   PUMA↑, 1,   survivin↓, 8,   Telomerase↓, 1,   TumCD↑, 1,   YAP/TEAD↓, 1,  

Kinase & Signal Transduction ⓘ

HER2/EBBR2↓, 1,   SOX9↑, 1,   Sp1/3/4↓, 8,   Sp1/3/4↑, 1,  

Transcription & Epigenetics ⓘ

cJun↑, 1,   EZH2↓, 1,   miR-21↓, 1,   miR-27a-3p↓, 1,   other↓, 3,   other↑, 1,   other↝, 1,   tumCV↓, 6,  

Protein Folding & ER Stress ⓘ

ATF6↑, 2,   CHOP↑, 4,   p‑eIF2α↑, 2,   ER Stress↑, 5,   GRP78/BiP↓, 1,   GRP78/BiP↑, 2,   GRP94↑, 1,   HSP27↓, 1,   IRE1↑, 1,   PERK↑, 2,   UPR↑, 2,   XBP-1↑, 1,  

Autophagy & Lysosomes ⓘ

Beclin-1↓, 1,   BNIP3↑, 1,   p62↓, 2,   p62↑, 1,   TumAuto↓, 1,   TumAuto↑, 2,  

DNA Damage & Repair ⓘ

ATM↑, 1,   BRCA1↑, 1,   p‑CHK1↑, 1,   DNAdam↓, 1,   DNAdam↑, 3,   DNMTs↓, 2,   P53↑, 10,   p53 Wildtype∅, 1,   PARP↑, 1,   p‑PARP↑, 1,   cl‑PARP↑, 2,   cl‑PARP1↑, 1,   RAD51↓, 1,   SIRT6↑, 1,   TP53↑, 1,   γH2AX↑, 3,  

Cell Cycle & Senescence ⓘ

CDK2↓, 1,   CDK4↓, 1,   CDK4↝, 1,   cycA1/CCNA1↑, 1,   CycB/CCNB1↓, 1,   cycD1/CCND1↓, 9,   cycD1/CCND1↑, 1,   cycE/CCNE↑, 1,   P21↓, 1,   P21↑, 5,   TumCCA↑, 12,  

Proliferation, Differentiation & Cell State ⓘ

ALDH↓, 2,   ALDH1A1↓, 4,   Axin2↓, 1,   CD133↓, 6,   CD24↓, 1,   CD44↓, 6,   CSCs↓, 15,   EMT↓, 16,   EP4↑, 1,   ERK↓, 3,   p‑ERK↓, 1,   FGF↑, 1,   FOXO↑, 2,   FOXO4↓, 1,   Gli1↓, 6,   GSK‐3β↑, 2,   GSK‐3β↝, 2,   p‑GSK‐3β↓, 1,   HDAC↓, 3,   HDAC1↓, 1,   HDAC3↓, 1,   HDAC8↓, 1,   HH↓, 7,   IGF-1↓, 2,   IGF-1R↓, 1,   mTOR↓, 8,   Nanog↓, 3,   Nestin↓, 1,   NOTCH↓, 3,   NOTCH⇅, 1,   NOTCH1↓, 1,   NOTCH2↓, 1,   NOTCH2↑, 1,   OCT4↓, 4,   p300↓, 1,   PI3K↓, 7,   p‑PI3K↓, 1,   PTCH1↓, 2,   PTEN↑, 4,   RAS↓, 1,   Shh↓, 3,   Smo↓, 3,   SOX2↓, 3,   Src↓, 1,   STAT3↓, 8,   p‑STAT3↓, 2,   STAT5↓, 1,   TCF↓, 2,   TOP1?, 1,   TOP2↓, 1,   TumCG↓, 8,   Wnt↓, 8,   Wnt/(β-catenin)↓, 1,  

Migration ⓘ

5LO↓, 1,   ACTA2↓, 1,   AntiAg↑, 2,   Ca+2↓, 1,   Ca+2↑, 3,   Ca+2↝, 1,   CXCL12↓, 1,   E-cadherin↓, 2,   E-cadherin↑, 8,   FAK↓, 2,   Fibronectin↓, 1,   Fibronectin↑, 1,   GLI2↓, 1,   HLA↑, 1,   ITGB1↓, 1,   Ki-67↓, 3,   MALAT1↓, 3,   MMP2↓, 8,   MMP7↓, 2,   MMP9↓, 13,   MMPs↓, 4,   N-cadherin↓, 5,   N-cadherin↑, 1,   PKCδ↑, 1,   Rho↓, 1,   ROCK1↓, 2,   Slug↓, 3,   Smad1↓, 1,   SMAD2↓, 2,   p‑SMAD2↓, 1,   SMAD3↓, 2,   p‑SMAD3↓, 1,   Snail↓, 6,   Snail↑, 1,   SOX4↓, 1,   talin↓, 1,   TET1↑, 2,   TGF-β↓, 3,   TIMP1↑, 2,   TIMP2↑, 2,   TIMP3↑, 1,   TumCI↓, 13,   TumCMig↓, 8,   TumCP↓, 17,   TumMeta↓, 7,   Twist↓, 1,   TXNIP↑, 1,   uPA↓, 1,   uPAR↓, 1,   Vim?, 1,   Vim↓, 3,   Vim↑, 1,   Zeb1↓, 2,   α-SMA↓, 2,   β-catenin/ZEB1↓, 9,  

Angiogenesis & Vasculature ⓘ

angioG↓, 8,   ATF4↑, 1,   EGFR↓, 3,   Hif1a↓, 12,   Hif1a↑, 1,   PDGFR-BB↓, 1,   TXA2↑, 1,   VEGF↓, 9,   ZBTB10↑, 1,  

Barriers & Transport ⓘ

GLUT1↓, 4,  

Immune & Inflammatory Signaling ⓘ

CD4+↓, 1,   cellSen↑, 1,   COX2↓, 14,   CRP↓, 1,   CXCR2↑, 1,   CXCR4↓, 2,   FOXP3↓, 1,   IL1↓, 1,   IL10↓, 1,   IL18↓, 1,   IL1β↓, 2,   IL6↓, 6,   IL8↓, 2,   Inflam↓, 3,   JAK↓, 1,   JAK2↓, 1,   Macrophages↓, 1,   MCP1↓, 1,   Neut↓, 1,   NF-kB↓, 16,   p‑NF-kB↓, 2,   p65↓, 1,   PD-1↓, 1,   PD-L1↑, 1,   PGE2↓, 1,   PSA↓, 2,   T-Cell↓, 1,   T-Cell↑, 2,   Th1 response↑, 1,   TNF-α↓, 4,  

Protein Aggregation ⓘ

Aβ↓, 1,   NLRP3↓, 5,  

Hormonal & Nuclear Receptors ⓘ

AR↓, 4,   CDK6↓, 1,  

Drug Metabolism & Resistance ⓘ

BioAv↓, 5,   BioAv↑, 3,   BioAv↝, 1,   BioEnh?, 1,   ChemoSen↑, 15,   ChemoSen⇅, 1,   Dose?, 1,   Dose↑, 2,   Dose↝, 9,   eff↓, 4,   eff↑, 20,   eff↝, 3,   Half-Life↓, 1,   Half-Life↑, 1,   Half-Life↝, 3,   MDR1↓, 1,   P450↓, 1,   RadioS↑, 7,   selectivity↑, 1,  

Clinical Biomarkers ⓘ

AR↓, 4,   BRCA1↑, 1,   CRP↓, 1,   E6↓, 1,   EGFR↓, 3,   EZH2↓, 1,   HER2/EBBR2↓, 1,   IL6↓, 6,   Ki-67↓, 3,   LDH↓, 1,   PD-L1↑, 1,   PSA↓, 2,   TP53↑, 1,  

Functional Outcomes ⓘ

AntiAge↑, 1,   AntiTum↑, 3,   cardioP↑, 2,   chemoPv↑, 3,   ChemoSideEff↓, 1,   hepatoP↑, 1,   NKG2D↑, 1,   TumVol↓, 1,   TumW↓, 1,  

Infection & Microbiome ⓘ

CD8+↑, 1,  
Total Targets: 360

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress ⓘ

antiOx↑, 21,   Catalase↑, 7,   GPx↑, 5,   GSH↑, 9,   GSR↑, 2,   GSTs↑, 1,   H2O2↓, 1,   HO-1↑, 10,   HO-1⇅, 1,   Keap1↓, 3,   lipid-P↓, 5,   mt-lipid-P↓, 1,   MDA↓, 4,   Mets↝, 1,   MPO↓, 2,   NQO1↑, 3,   Nrf1?, 1,   NRF2↑, 11,   RNS↓, 1,   ROS↓, 21,   ROS↑, 1,   SIRT3↑, 1,   SOD↑, 7,  

Mitochondria & Bioenergetics ⓘ

ATP↑, 1,   Insulin↓, 1,   MMP↑, 2,   mtDam↓, 1,   PGC-1α↓, 1,   PGC-1α↑, 2,  

Core Metabolism/Glycolysis ⓘ

Acetyl-CoA↓, 1,   ALAT↓, 1,   AMPK↑, 10,   cMyc↑, 1,   p‑CREB↑, 2,   ECAR∅, 1,   FAO↑, 1,   FASN↓, 1,   G6PD↑, 1,   glucose↓, 1,   GlutMet↑, 1,   Glycolysis↝, 2,   HK2↑, 1,   LDHA↑, 2,   LDL↓, 1,   NAD↑, 1,   NADH:NAD↑, 1,   PDK1↓, 1,   p‑PDK1↓, 1,   PKM2↑, 2,   PPARγ↑, 2,   SIRT1↑, 20,   SIRT2↑, 1,   SREBP1↓, 1,  

Cell Death ⓘ

Akt↓, 1,   Akt↑, 1,   p‑Akt↓, 1,   Apoptosis↓, 2,   BAX↓, 1,   Bcl-2↑, 1,   Casp3↓, 1,   Cyt‑c∅, 1,   iNOS↓, 2,   iNOS↑, 1,   p38↑, 1,  

Kinase & Signal Transduction ⓘ

CaMKII ↓, 1,   Sp1/3/4↓, 3,   Sp1/3/4↑, 1,  

Transcription & Epigenetics ⓘ

other?, 1,   other↑, 2,  

Protein Folding & ER Stress ⓘ

HSP70/HSPA5↝, 1,  

Autophagy & Lysosomes ⓘ

Beclin-1↑, 1,   p62↓, 1,  

Cell Cycle & Senescence ⓘ

P21↑, 1,  

Proliferation, Differentiation & Cell State ⓘ

CLOCK↝, 1,   ERK↓, 1,   FOXO↑, 2,   FOXO1↝, 1,   GSK‐3β↓, 3,   GSK‐3β↑, 1,   IGF-1↓, 2,   IGFBP3↑, 1,   IGFR↓, 1,   PI3K↑, 2,   PTEN↑, 1,  

Migration ⓘ

AntiAg↑, 6,   miR-155↓, 1,   miR-29b↑, 1,   MMP3↓, 1,   MMP9↓, 5,   PKA↑, 1,  

Angiogenesis & Vasculature ⓘ

angioG↑, 1,   eNOS↑, 1,   Hif1a↓, 1,   NO↓, 2,   VEGF↓, 1,   VEGF↑, 1,  

Barriers & Transport ⓘ

BBB↓, 1,   BBB↑, 1,   GLUT1↓, 1,  

Immune & Inflammatory Signaling ⓘ

COX2↓, 4,   IL1β↓, 4,   IL6↓, 2,   Inflam↓, 16,   NF-kB↓, 6,   NF-kB↑, 1,   p‑NF-kB↓, 1,   p65↓, 1,   PGE2↓, 1,   TLR4↓, 1,   TNF-α↓, 2,  

Synaptic & Neurotransmission ⓘ

AChE↓, 1,   ADAM10↑, 6,   BDNF↑, 4,   PSD95↑, 1,   tau↓, 1,   p‑tau↓, 6,  

Protein Aggregation ⓘ

Aβ↓, 8,   BACE↓, 3,   NLRP3↓, 4,   PP2A↑, 4,  

Drug Metabolism & Resistance ⓘ

BioAv↓, 7,   BioAv↑, 5,   BioAv↝, 2,   BioEnh↑, 1,   Dose↓, 1,   Dose↝, 2,   eff↑, 5,   Half-Life↓, 2,   Half-Life↝, 1,  

Clinical Biomarkers ⓘ

ALAT↓, 1,   AST↓, 1,   BP↓, 1,   IL6↓, 2,  

Functional Outcomes ⓘ

AntiAge↑, 2,   AntiCan↑, 2,   cardioP↑, 6,   chemoPv↑, 3,   cognitive↑, 6,   hepatoP↑, 3,   memory↑, 7,   motorD↑, 1,   neuroP↑, 17,   OS↑, 1,   radioP↑, 1,   RenoP↑, 2,   toxicity↓, 3,   toxicity↑, 1,   toxicity∅, 1,   Weight↑, 1,  
Total Targets: 149

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:141  Target#:%  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page